- $1.47bn
- $1.58bn
- $418.84m
Brief: Certara Inc - Size Of Board Was Increased From Nine To Ten Directors
Brief: Certara Completes Acquisition Of Chemaxon
Brief: Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy For Potential First-In-Class Cancer Drug
U.S. RESEARCH ROUNDUP-Amgen, Atkore, Moneylion
Certara Inc reports results for the quarter ended in June - Earnings Summary
Brief: Certara Q2 Adjusted EPS USD 0.07 Vs. IBES Estimate USD 0.1
Certara Inc expected to post earnings of 10 cents a share - Earnings Preview
Brief: Certara To Acquire Chemaxon To Strengthen Drug Discovery Software Portfolio
Brief: Certara Appoints New Chief Human Resources Officer & General Counsel
Brief: Certara Q1 Adjusted EPS USD 0.1 Vs. IBES Estimate USD 0.1
Certara Inc expected to post earnings of 10 cents a share - Earnings Preview
Certara Inc reports results for the quarter ended in December - Earnings Summary
Brief: Certara Q4 Adjusted EPS USD 0.09 Vs. IBES Estimate USD 0.11
Certara Inc expected to post earnings of 11 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Array Technologies, Autodesk, Nike
U.S. RESEARCH ROUNDUP- Ameren Corp, Bread Financial Holdings, Exelon Corp
Brief: Certara Acquires Applied Biomath
U.S. RESEARCH ROUNDUP-Caredx, Ebix, Vera Therapeutics
U.S. RESEARCH ROUNDUP-Axon Enterprise, Duolingo, Hubspot